metoprolol has been researched along with Myocarditis in 17 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to compare the effects of carvedilol and metoprolol in alleviating viral myocarditis (VMC) induced by coxsackievirus B3 (CVB3) in mice." | 7.80 | Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis. ( Chen, C; Chen, Q; Chen, Y; Chu, M; Jiang, J; Pan, L; Qian, Y; Wang, D; Zhou, A, 2014) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 7.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 7.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "This study was designed to examine the effects of carvedilol in a murine model of viral myocarditis induced by encephalomyocarditis virus (EMCV) infection." | 7.72 | Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. ( Matsumori, A; Nishio, R; Sasayama, S; Shioi, T, 2003) |
| "We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties." | 7.72 | Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 7.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| "We evaluated acute hemodynamic effects of metoprolol +/- nitroglycerin in 11 patients with left ventricular dysfunction and biopsy-proven lymphocytic myocarditis." | 7.70 | Acute hemodynamic effects of metoprolol +/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis. ( Bojić, M; Mirić, M; Popović, AD; Popović, Z; Sagić, D; Vasiljević, J, 1998) |
| "This study was designed to examine the effects of denopamine, a selective beta1-adrenergic agonist, in a murine model of congestive heart failure (CHF) due to viral myocarditis." | 7.70 | Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. ( Matsumori, A; Nishio, R; Ono, K; Sasayama, S; Shioi, T; Wang, W; Yamada, T, 1998) |
| "Treatment with metoprolol reduced insignificantly the viral load and body weight loss (experiment A and B) but led to a significant reduction of myocardial histopathology in experiment A." | 5.36 | Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis. ( Dahlke, K; Decker, M; Glück, B; Krumbholz, A; Lehmann, J; Wutzler, P; Zell, R, 2010) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 3.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 3.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "This study was designed to examine the effects of carvedilol in a murine model of viral myocarditis induced by encephalomyocarditis virus (EMCV) infection." | 3.72 | Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. ( Matsumori, A; Nishio, R; Sasayama, S; Shioi, T, 2003) |
| "We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties." | 3.72 | Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 3.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| "We evaluated acute hemodynamic effects of metoprolol +/- nitroglycerin in 11 patients with left ventricular dysfunction and biopsy-proven lymphocytic myocarditis." | 3.70 | Acute hemodynamic effects of metoprolol +/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis. ( Bojić, M; Mirić, M; Popović, AD; Popović, Z; Sagić, D; Vasiljević, J, 1998) |
| "This study was designed to examine the effects of denopamine, a selective beta1-adrenergic agonist, in a murine model of congestive heart failure (CHF) due to viral myocarditis." | 3.70 | Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. ( Matsumori, A; Nishio, R; Ono, K; Sasayama, S; Shioi, T; Wang, W; Yamada, T, 1998) |
| "Treatment with metoprolol reduced insignificantly the viral load and body weight loss (experiment A and B) but led to a significant reduction of myocardial histopathology in experiment A." | 1.36 | Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis. ( Dahlke, K; Decker, M; Glück, B; Krumbholz, A; Lehmann, J; Wutzler, P; Zell, R, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plümacher, KS | 1 |
| Paul, T | 1 |
| Sigler, M | 1 |
| Wang, D | 1 |
| Chen, Y | 1 |
| Jiang, J | 1 |
| Zhou, A | 1 |
| Pan, L | 1 |
| Chen, Q | 1 |
| Qian, Y | 1 |
| Chu, M | 1 |
| Chen, C | 1 |
| Manov, A | 1 |
| Gopalakrishnan, PP | 1 |
| Subramaniam, S | 1 |
| Wardi, M | 1 |
| White, J | 1 |
| Patel, RA | 1 |
| Glover, DK | 1 |
| Broisat, A | 1 |
| Kabul, HK | 1 |
| Ruiz, M | 1 |
| Goodman, NC | 1 |
| Kramer, CM | 1 |
| Meerdink, DJ | 1 |
| Linden, J | 1 |
| Beller, GA | 1 |
| Li, YC | 1 |
| Ge, LS | 1 |
| Yang, PL | 1 |
| Tang, JF | 1 |
| Lin, JF | 1 |
| Chen, P | 1 |
| Guan, XQ | 1 |
| Glück, B | 1 |
| Dahlke, K | 1 |
| Zell, R | 1 |
| Krumbholz, A | 1 |
| Decker, M | 1 |
| Lehmann, J | 1 |
| Wutzler, P | 1 |
| Nishio, R | 2 |
| Shioi, T | 2 |
| Sasayama, S | 2 |
| Matsumori, A | 2 |
| Yuan, Z | 2 |
| Shioji, K | 2 |
| Kihara, Y | 1 |
| Takenaka, H | 1 |
| Onozawa, Y | 1 |
| Kishimoto, C | 2 |
| Liu, K | 1 |
| Liao, YH | 1 |
| Wang, ZH | 1 |
| Li, SL | 1 |
| Wang, M | 1 |
| Zeng, LL | 1 |
| Tang, M | 1 |
| Nimata, M | 1 |
| Tschöpe, C | 2 |
| Westermann, D | 2 |
| Steendijk, P | 1 |
| Noutsias, M | 2 |
| Rutschow, S | 2 |
| Weitz, A | 2 |
| Schwimmbeck, PL | 1 |
| Schultheiss, HP | 2 |
| Pauschinger, M | 2 |
| Chandrasekharan, K | 1 |
| Peter Schwimmbeck, L | 1 |
| Zeichhardt, H | 1 |
| Poller, W | 1 |
| Li, J | 1 |
| Frustaci, A | 1 |
| Verardo, R | 1 |
| Sale, P | 1 |
| Toscano, F | 1 |
| Critelli, G | 1 |
| Russo, MA | 1 |
| Chimenti, C | 1 |
| Yue-Chun, L | 1 |
| Li-Sha, G | 1 |
| Jiang-Hua, R | 1 |
| Peng-Lin, Y | 1 |
| Jia-Feng, L | 1 |
| Ji-Fei, T | 1 |
| Peng, C | 1 |
| Zhan-Qiu, Y | 1 |
| Popović, Z | 1 |
| Mirić, M | 1 |
| Vasiljević, J | 1 |
| Sagić, D | 1 |
| Bojić, M | 1 |
| Popović, AD | 1 |
| Wang, W | 1 |
| Yamada, T | 1 |
| Ono, K | 1 |
| Rezkalla, S | 1 |
| Kloner, RA | 1 |
| Khatib, G | 1 |
| Smith, FE | 1 |
| Khatib, R | 1 |
17 other studies available for metoprolol and Myocarditis
| Article | Year |
|---|---|
Expectoration of bronchial casts in association with Ramipril treatment.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Bronchi; Fe | 2019 |
Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis.
Topics: Animals; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Cytokines; Enterovirus B, Human; Metoprolol | 2014 |
Chest pain · shortness of breath · fever and nausea · Dx?
Topics: Adult; Antihypertensive Agents; Chest Pain; Diagnosis, Differential; Diuretics; Electrocardiography; | 2015 |
Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.
Topics: Adenosine A2 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Combined Modality T | 2009 |
Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
Topics: Adrenergic Antagonists; Aldehydes; Animals; Body Weight; Carbazoles; Carvedilol; Electrocardiography | 2010 |
Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Coxsackievirus Infections; Enterovirus B, Human; He | 2010 |
Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiovirus Infections; Carvedilol; Dose-Response | 2003 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Autoimm | 2004 |
Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Autoantibodies; Calci | 2004 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis.
Topics: Administration, Oral; Animals; Autoimmune Diseases; Carbazoles; Cardiotonic Agents; Carvedilol; Dose | 2004 |
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.
Topics: Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Male; Metoprolol; Mice; Mice, Inbred BAL | 2004 |
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Interleukin | 2005 |
Hypersensitivity myocarditis induced by beta-blockers: an unexpected cause of abrupt deterioration in hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Hypertrophic; Drug Hypersensitivity; Female; Hum | 2007 |
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo | 2008 |
Acute hemodynamic effects of metoprolol +/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis.
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Hemodynamics; Humans; Lymphoc | 1998 |
Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Cardiovirus Infe | 1998 |
Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Metoprolol; Mice; Myocarditis; Myocardium | 1988 |